当前位置: X-MOL 学术Stem Cell Res. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells
Stem Cell Research & Therapy ( IF 7.5 ) Pub Date : 2021-09-06 , DOI: 10.1186/s13287-021-02566-5
Bing-Zhou Xue 1 , Wei Xiang 1 , Qing Zhang 1, 2 , Hao-Fei Wang 1 , Yu-Jie Zhou 1 , Han Tian 1 , Ahmed Abdelmaksou 1, 3 , Jian Xue 4 , Min-Xuan Sun 5 , Dong-Ye Yi 1 , Nan-Xiang Xiong 1 , Xiao-Bing Jiang 1 , Hong-Yang Zhao 1 , Peng Fu 1
Affiliation  

The original article [1] contained an error in Fig. 3B which was given wrong marking figures of NC.U87(0h) and KD.U87(0h).

Fig. 3
figure3

FOXS1 overexpression induces TMZ resistance in glioma cells. The proliferation (A), wound-healing (B) and apoptosis assay (C) of glioma cells with different FOXS1 expression under 200 μM TMZ treatment. control, normal control; NC, negative control; KD, knockdown; OE, overexpression (n ≥ 3, *P < 0.05, ***P < 0.001)

Full size image

The original figures and data of Fig. 3 were checked by the authors and the editors of this article, no more figure or data was changed.

The corrected Fig. 3 is presented ahead.

  1. 1.

    Bing-zhou X, et al. CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Stem Cell Res Ther. 2021;12:394. https://doi.org/10.1186/s13287-021-02458-8.

    Article Google Scholar

Download references

Author notes
  1. Bing-zhou Xue and Wei Xiang contributed equally to this work

Affiliations

  1. Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Bing-zhou Xue, Wei Xiang, Qing Zhang, Hao-fei Wang, Yu-jie Zhou, Han Tian, Ahmed Abdelmaksou, Dong-ye Yi, Nan-xiang Xiong, Xiao-bing Jiang, Hong-yang Zhao & Peng Fu

  2. Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, 100050, China

    Qing Zhang

  3. Department of Neurosurgery, Faculty of Medicine, Helwan University, Cairo, 11435, Egypt

    Ahmed Abdelmaksou

  4. Henan Vocational University of Science and Technology, Zhoukou, 466000, China

    Jian Xue

  5. Jiangsu Key Lab of Medical Optics, Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences, Suzhou, 215163, China

    Min-xuan Sun

Authors
  1. Bing-zhou XueView author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei XiangView author publications

    You can also search for this author in PubMed Google Scholar

  3. Qing ZhangView author publications

    You can also search for this author in PubMed Google Scholar

  4. Hao-fei WangView author publications

    You can also search for this author in PubMed Google Scholar

  5. Yu-jie ZhouView author publications

    You can also search for this author in PubMed Google Scholar

  6. Han TianView author publications

    You can also search for this author in PubMed Google Scholar

  7. Ahmed AbdelmaksouView author publications

    You can also search for this author in PubMed Google Scholar

  8. Jian XueView author publications

    You can also search for this author in PubMed Google Scholar

  9. Min-xuan SunView author publications

    You can also search for this author in PubMed Google Scholar

  10. Dong-ye YiView author publications

    You can also search for this author in PubMed Google Scholar

  11. Nan-xiang XiongView author publications

    You can also search for this author in PubMed Google Scholar

  12. Xiao-bing JiangView author publications

    You can also search for this author in PubMed Google Scholar

  13. Hong-yang ZhaoView author publications

    You can also search for this author in PubMed Google Scholar

  14. Peng FuView author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peng Fu.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

Verify currency and authenticity via CrossMark

Cite this article

Xue, Bz., Xiang, W., Zhang, Q. et al. Correction to: CD90low glioma-associated mesenchymal stromal/stem cells promote temozolomide resistance by activating FOXS1-mediated epithelial-mesenchymal transition in glioma cells. Stem Cell Res Ther 12, 493 (2021). https://doi.org/10.1186/s13287-021-02566-5

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13287-021-02566-5

更新日期:2021-09-06
down
wechat
bug